Loading...

Predilife S.A.

ALPRE.PAEURONEXT
Healthcare
Medical - Diagnostics & Research
3.18
0.09(2.91%)
U.S. Market opens in 3h 57m

Predilife S.A. Fundamental Analysis

Predilife S.A. (ALPRE.PA) shows moderate financial fundamentals with a PE ratio of -3.00, profit margin of -5.21%, and ROE of 39.39%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE39.39%
PEG Ratio-0.27

Areas of Concern

Operating Margin-7.40%
Cash Position3.88%
Current Ratio0.45
We analyze ALPRE.PA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -432.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-432.8/100

We analyze ALPRE.PA's fundamental strength across five key dimensions:

Efficiency Score

Weak

ALPRE.PA struggles to generate sufficient returns from assets.

ROA > 10%
-2.90%

Valuation Score

Excellent

ALPRE.PA trades at attractive valuation levels.

PE < 25
-3.00
PEG Ratio < 2
-0.27

Growth Score

Weak

ALPRE.PA faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ALPRE.PA shows balanced financial health with some risks.

Debt/Equity < 1
-0.33
Current Ratio > 1
0.45

Profitability Score

Weak

ALPRE.PA struggles to sustain strong margins.

ROE > 15%
39.39%
Net Margin ≥ 15%
-5.21%
Positive Free Cash Flow
No

Key Financial Metrics

Is ALPRE.PA Expensive or Cheap?

P/E Ratio

ALPRE.PA trades at -3.00 times earnings. This suggests potential undervaluation.

-3.00

PEG Ratio

When adjusting for growth, ALPRE.PA's PEG of -0.27 indicates potential undervaluation.

-0.27

Price to Book

The market values Predilife S.A. at -0.76 times its book value. This may indicate undervaluation.

-0.76

EV/EBITDA

Enterprise value stands at -1.60 times EBITDA. This is generally considered low.

-1.60

How Well Does ALPRE.PA Make Money?

Net Profit Margin

For every $100 in sales, Predilife S.A. keeps $-5.21 as profit after all expenses.

-5.21%

Operating Margin

Core operations generate -7.40 in profit for every $100 in revenue, before interest and taxes.

-7.40%

ROE

Management delivers $39.39 in profit for every $100 of shareholder equity.

39.39%

ROA

Predilife S.A. generates $-2.90 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.90%

Following the Money - Real Cash Generation

Operating Cash Flow

Predilife S.A. generates limited operating cash flow of $-1.60M, signaling weaker underlying cash strength.

$-1.60M

Free Cash Flow

Predilife S.A. generates weak or negative free cash flow of $-1.60M, restricting financial flexibility.

$-1.60M

FCF Per Share

Each share generates $-0.41 in free cash annually.

$-0.41

FCF Yield

ALPRE.PA converts -12.55% of its market value into free cash.

-12.55%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.27

vs 25 benchmark

P/B Ratio

Price to book value ratio

-0.76

vs 25 benchmark

P/S Ratio

Price to sales ratio

16.57

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.33

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.45

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.39

vs 25 benchmark

ROA

Return on assets percentage

-2.90

vs 25 benchmark

ROCE

Return on capital employed

3.85

vs 25 benchmark

How ALPRE.PA Stacks Against Its Sector Peers

MetricALPRE.PA ValueSector AveragePerformance
P/E Ratio-3.0027.91 Better (Cheaper)
ROE39.39%687.00% Weak
Net Margin-521.47%-45285.00% (disorted) Weak
Debt/Equity-0.330.33 Strong (Low Leverage)
Current Ratio0.452795.76 Weak Liquidity
ROA-290.43%-13557.00% (disorted) Weak

ALPRE.PA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Predilife S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ